The global skin care industry is entering a decisive phase of structural transformation, where beauty is increasingly converging with long-term skin health and clinical performance. According to the latest strategic outlook by Future Market Insights (FMI), the global Rebalancing Skin Care Products Market—valued at USD 155.9 billion in 2026—is projected to reach USD 249.1 billion by 2036, expanding at a steady CAGR of 4.8% over the forecast period. The report...

Like last year, 2026 appears poised to herald the arrival of multiple mega-blockbusters—albeit on an even grander scale than 2025’s plenty-respectable slate of major rollouts. According to Evaluate’s annual analysis of the biggest potential drug launches of the coming year, the top 10 most anticipated meds could generate a combined $45.9 billion in annual sales by 2032. That’s a massive jump from the $29 billion figure that Evaluate calculated for last year’s top 10, which itself was the highest total in years. In fact, combined sales from the top two drugs on...